Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study

Table 5

Univariate analysis of variables associated with inadequate adherence to biologics.

	Inadequate adherence group ()	Adequate adherence group ()	Univariate analysis
			OR (CI95%)
Gender (% male)	35.29 (12/34)	42.62 (52/122)	0.74 (0.35-1.58)	0.4
Age, median (IQR)	37 (22-69)	37 (21-72)	N/A	0.5
Years since diagnosis, median (IQR)	6 (1-33)	6 (1-26)	N/A	0.9
Primary level of education (%)	5.88 (2/34)	9.01 (11/122)	0.56 (0.12-2.62)	0.4
Live alone (%)	11.76 (4/34)	20.49 (25/122)	0.48 (0.15-1.46)	0.2
Disability certificate (%)	29.41 (10/34)	30.32 (37/122)	0.87 (0.39-1.94)	0.7
Health coverage (% union-funded health insurance)	44.11 (15/34)	51.64 (63/122)	0.74 (0.35-1.54)	0.4
Smoking (%)	11.76 (4/34)	13.93 (17/122)	0.96 (0.33-2.73)	0.9
History of IBD-related surgery (%)	23.52 (8/34)	18.03 (22/122)	1.39 (0.56-3.49)	0.6
History of hospitalization due to IBD (%)	55.88 (19/34)	58.19 (71/122)	0.87 (0.42-1.83)	0.7
>5 consultations in the last year (%)	70.59 (24/34)	63.93 (78/122)	1.43 (0.64-3.2)	0.3
Satisfaction with number of consultations (%)	76.47 (26/34)	82.78 (101/122)	0.71 (0.29-1.73)	0.4
Perception of easy contact (%)	82.35 (28/34)	85.24 (104/122)	0.84 (0.31-2.24)	0.7
Satisfaction with gastroenterologist’s care (%)	88.23 (30/34)	90.98 (111/122)	0.76 (0.23-2.49)	0.6
Communication with gastroenterologist via email or text messages (%)	64.71 (22/34)	70.49 (86/122)	0.83 (0.38-1.81)	0.6
Use chronic medication for other indication than IBD (%)	32.35 (11/34)	27.05 (33/122)	1.31 (0.6-2.86)	0.4

IBD: inflammatory bowel disease; IQR: interquartile range; OR: odds ratio; CI: confidence interval.